The diagnosis of SLE was made according to the 2019 EULAR criteria, based on the combination of inflammatory polyarthralgia, lymphopenia, a high-titer ANA, the positivity of specific antibodies like anti-Sm and anti-dsDNA, and consumption of C3 and C4 complement fractions. This evidence concerns the gene C4A and systemic lupus erythematosus.